Completed OBSERVATIONAL NCT01122212

Introduction of Protein S100 in Diagnostics in Minor Brain Injury Patients at Our Hospital (S100)

Introduction of Protein S100 in the Routine Diagnostics in Patients With Minor Head Injury

Sponsor: Kantonsspital Münsterlingen

Updated 10 times since 2017 Last updated: Apr 17, 2015 Started: Jan 31, 2010 Primary completion: Jul 31, 2010 Completion: Jan 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01122212, this observational or N/A phase trial focuses on Intracerebral Hemorrhage and remains completed. Sponsored by Kantonsspital Münsterlingen, it has been updated 10 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kantonsspital Münsterlingen
Roche Diagnostic Ltd.

Data source: Kantonsspital Münsterlingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Münsterlingen, Switzerland